Legislation
- Title
- Health Insurance - Prescription Insulin Drugs - Limits on Copayment and Coinsurance (Insulin Cost Reduction Act)
- Sponsored by
- Delegates Pena-Melnyk, Bagnall, B. Barnes, Carey, Charles, Henson, Howell, Landis, Lehman, Reznik, Valderrama, Valentino-Smith, Bhandari, Carr, Chisholm, Cullison, Hill, Johnson, Kaiser, Kelly, Kerr, Kipke, R. Lewis, Morgan, Pendergrass, Reilly, Rosenberg, Saab, Sample-Hughes, Szeliga, and K. Young
- Status
- Approved by the Governor - Chapter 405
- Analysis
- Fiscal and Policy Note (Revised)
Synopsis
Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments or coinsurance for a covered prescription insulin drug to not more than $30 for a 30-day supply.
Committees
- Opposite:
- Finance
Committee Testimony
Details
History
Toggle History Dropdown
File Code
Toggle Filecode Dropdown
Subjects
Toggle Subjects Dropdown
Statutes
Toggle Statutes Dropdown
(
15-822.1, 15-847.1 )
Last Updated: 7/8/2022 2:42 PM